Woo Raymond, the Chief Technology Officer of Ceribell, Inc., has disclosed several stock transactions in a recent SEC filing. The transactions, reported on November 4, 2026, include the acquisition of shares through stock options and the sale of a portion of his holdings. This activity is significant as it highlights the ongoing movements within the electromedical industry, where Ceribell operates.

Ceribell, Inc. is a company focused on developing innovative medical technologies. The firm is categorized under electromedical and electrotherapeutic apparatus, which is crucial in the healthcare sector. The company's CIK is 0001861107, and it is publicly traded under the ticker symbol CBLL.

According to the SEC filing, Woo Raymond executed multiple transactions on November 2, 2026. He acquired 4,864 shares at a price of $3.65 each and an additional 23 shares at $4.70 each. Additionally, he sold 4,887 shares at a price of $26.96 each. Following these transactions, he holds a total of 203,118 shares.

The filing indicates that these transactions were made under a Rule 10b5-1 trading plan adopted on June 5, 2026. This plan allows corporate insiders to set up a predetermined schedule for buying or selling stocks to avoid accusations of insider trading.

The impact of these transactions may resonate with investors and analysts monitoring Ceribell's performance and strategy in the electromedical sector. As the company continues to innovate and expand its offerings, such insider activities could influence market perceptions and investor confidence.

Details were not available in the SEC filing regarding any future plans or additional transactions. The filing does not say what happens next.